# The Medicines (Products for Human Use) (Fees) Regulations 2016, Regulation 5: Fee for scientific advice: classification of a medicinal product


(1) The fee payable by a person with whom the licensing authority holds a meeting to provide scientific advice in connection with the classification of a relevant medicinal product, is—
(a) £8,758, if the advice relates to a product which, if reclassified, will be available on general sale; and
(b) £8,758, if the advice relates to a product which, if reclassified, will be available without a prescription from a pharmacy.
(2) For the purposes of this regulation, a product is on general sale if it is a medicinal product subject to general sale within the meaning of regulation 5(1) of the Human Medicines Regulations (classification of medicinal products for general sale).

---
Source: https://www.legislation.gov.uk/uksi/2016/190/regulation/5 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2016/regulation-5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.